Preparation of Peppermint Oil-Based Nanodevices Loaded with Paclitaxel: Cytotoxic and Apoptosis Studies in HeLa Cells

被引:0
作者
Sergio E. Flores-Villaseñor
René D. Peralta-Rodríguez
Felipe Padilla-Vaca
H. Iván Meléndez-Ortiz
Jorge C. Ramirez-Contreras
Bernardo Franco
机构
[1] Centro de Investigación en Química Aplicada,Departamento de Biología, División de Ciencias Naturales y Exactas
[2] Universidad de Guanajuato,undefined
[3] CONACyT- Centro de Investigación en Química Aplicada,undefined
来源
AAPS PharmSciTech | / 20卷
关键词
microemulsions; nanodevices; drug delivery; peppermint oil; paclitaxel; cytotoxicity;
D O I
暂无
中图分类号
学科分类号
摘要
In this work, several normal, oil-in-water (o/w) microemulsions (MEs) were prepared using peppermint essential oil, jojoba oil, trans-anethole, and vitamin E as oil phases to test their capacity to load paclitaxel (PTX). Initially, pseudo-ternary partial phase diagrams were constructed in order to find the normal microemulsion region using d-α-tocopherol polyethylene glycol 1000 succinate (TPGS-1000) as surfactant and isobutanol (iso-BuOH) as co-surfactant. Selected ME formulations were loaded with PTX reaching concentrations of 0.6 mg mL−1 for the peppermint oil and trans-anethole MEs, while for the vitamin E and jojoba oil MEs, the maximum concentration was 0.3 mg mL−1. The PTX-loaded MEs were stable according to the results of heating–cooling cycles and mechanical force (centrifugation) test. Particularly, drug release profile for the PTX-loaded peppermint oil ME (MEPP) showed that ∼ 90% of drug was released in the first 48 h. Also, MEPP formulation showed 70% and 90% viability reduction on human cervical cancer (HeLa) cells after 24 and 48 h of exposure, respectively. In addition, HeLa cell apoptosis was confirmed by measuring caspase activity and DNA fragmentation. Results showed that the MEPP sample presented a major pro-apoptotic capability by comparing with the unloaded PTX ME sample.
引用
收藏
相关论文
共 183 条
  • [1] Mu L(2003)A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGS J Control Release 86 33-48
  • [2] Feng SS(2008)Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis Int J Pharm 349 108-116
  • [3] Nornoo AO(2011)A novel paclitaxel microemulsion containing a reduced amount of Cremophor EL: pharmacokinetics, biodistribution, and in vivo antitumor efficacy and safety J Biomed Biotechnol 2011 854872-137
  • [4] Osborne DW(2008)Polymeric nanomedicine for cancer therapy Prog Polym Sci 33 113-2681
  • [5] Chow DS(2014)How Taxol/paclitaxel kills cancer cells Mol Biol Cell 25 2677-2332
  • [6] Wang Y(2010)Self-emulsifying O/W formulations of paclitaxel prepared from mixed nonionic surfactants J Pharm Sci 99 2320-1148
  • [7] Wu KC(2017)Development of safe and potent oil-in-water emulsion of paclitaxel to treat peritoneal dissemination J Pharm Sci 106 1143-5737
  • [8] Zhao BX(2018)Paclitaxel-loaded pH-sensitive liposome: new insights on structural and physicochemical characterization Langmuir 34 5728-119
  • [9] Zhao X(2014)Bioresponsive nanohydrogels based on HEAA and NIPA for poorly soluble drugs delivery Int J Pharm 470 107-624
  • [10] Wang X(2015)Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles Int J Pharm 478 617-880